Most cited papers from Pulmatrix (United States)

Pulmatrix (United States)

What are the most cited papers from Pulmatrix (United States)?

The most cited paper from Pulmatrix (United States) is "Influenza Virus in Human Exhaled Breath: An Observational Study" (Maria Patricia Fabian, James McDevitt, Wesley H. DeHaan et al., 2008), with 523 citations. Next come "Inhaling to mitigate exhaled bioaerosols" (383) and "Airborne infectious disease and the suppression of pulmonary bioaerosols" (189).

Published TypeFieldAccessCitations

Showing 30 of 30 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Influenza Virus in Human Exhaled Breath: An Observational Study Maria Patricia Fabian, James McDevitt, Wesley H. DeHaan et al. · PLoS ONE Open access	15 Jul 2008	523
2	Inhaling to mitigate exhaled bioaerosols David Albert Edwards, Jonathan C. Man, Peter Brand et al. · Proceedings of the National Academy of Sciences Open access	6 Dec 2004	383
3	Airborne infectious disease and the suppression of pulmonary bioaerosols Jennifer Fiegel, Robert W. Clarke, David Albert Edwards · Drug Discovery Today Open access	2006	189
4	Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene Blanca E. Himes et al. · PLoS Genetics Open access	5 Jul 2012	125
5	Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs Lucila Garcia Contreras, Jean C. Sung, Mariam Ibrahim et al. · Molecular Pharmaceutics	5 May 2015	69
6	A genome-wide association study of bronchodilator response in asthmatics Qing Duan et al. · The Pharmacogenomics Journal Open access	19 Mar 2013	54
7	Role of Toll-like receptor-4 in genetic susceptibility to lung injury induced by residual oil fly ash Hye‐Youn Cho, Anne Jedlicka, Robert W. Clarke et al. · Physiological Genomics	23 Mar 2005	41
8	Why inhaling salt water changes what we exhale Wiwik Watanabe, Matthew James Thomas, Robert W. Clarke et al. · Journal of Colloid and Interface Science	16 Nov 2006	39
9	A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics David L. Hava, Lisa Tan, Patrick W. Johnson et al. · British Journal of Clinical Pharmacology Open access	7 Nov 2019	37
10	The Influence of Breathing Pattern During Nebulization on the Delivery of Arformoterol Using a Breath Simulator Andrea Bauer, Paul McGlynn, Li Li Bovet et al. · Respiratory Care	Nov 2009	32
11	Characteristics of exhaled particle production in healthy volunteers: possible implications for infectious disease transmission Fatima B. Wurie, Olivier le Polain de Waroux, Matthew Brande et al. · F1000Research Open access	15 Jan 2013	30
12	Output and Aerosol Properties of 5 Nebulizer/Compressor Systems With Arformoterol Inhalation Solution Andrea Bauer, Paul McGlynn, Li Li Bovet et al. · Respiratory Care	Oct 2009	23
13	A New Natural Defense Against Airborne Pathogens David Albert Edwards, Anthony James Hickey, Richard P. Batycky et al. · QRB Discovery Open access	2020	22
14	Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs Lucila Garcia‐Contreras, Danielle J. Padilla-Carlin, Jean C. Sung et al. · Journal of Pharmaceutical Sciences Open access	11 Nov 2016	22
15	Calcium Restores the Macrophage Response to Nontypeable Haemophilus influenzae in Chronic Obstructive Pulmonary Disease Karin A. Provost, Miyuki Smith, Stephen P. Arold et al. · American Journal of Respiratory Cell and Molecular Biology	22 Oct 2014	17
16	The pharmacokinetics, pharmacodynamics and tolerability of PUR0200, a novel tiotropium formulation, in chronic obstructive pulmonary disease Dave Singh, Arjun Ravi, Katie Kane et al. · British Journal of Clinical Pharmacology Open access	23 May 2018	14
17	Allergic Diseases Caused by Aspergillus Species in Patients with Cystic Fibrosis Aidan K. Curran, David L. Hava · Antibiotics Open access	28 Mar 2021	12
18	Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets Philip J. Kuehl, Ramesh Chand, Jacob D. McDonald et al. · AAPS PharmSciTech	Jul 2019	9
19	Particle size and gastrointestinal absorption influence tiotropium pharmacokinetics: a pilot bioequivalence study of PUR0200 and Spiriva HandiHaler Jason K. Perry, Brian G. Trautman, Joe Takher‐Smith et al. · British Journal of Clinical Pharmacology Open access	6 Dec 2018	9
20	Efficacy and safety of inhaled calcium lactate PUR118 in the ozone challenge model - a clinical trial Olaf Holz, Heike Biller, Meike Mueller et al. · BMC Pharmacology and Toxicology Open access	11 Aug 2015	9
21	A cumulative dose, safety and tolerability study of arformoterol in pediatric subjects with stable asthma James E. Hinkle, Jacquelyn R. Hinson, Edward Kerwin et al. · Pediatric Pulmonology	16 May 2011	9
22	Pulmonary delivery of anti-contagion aerosol to diminish exhaled bioaerosols and airborne infectious disease Robert W. Clarke, Jeffrey P. Katstra, Jonathan C. Man et al. · American Journal of Infection Control	Jun 2005	9
23	The effects of an epithelial barrier protective cationic aerosol on allergen‐induced airway inflammation in asthma: a randomized, placebo‐controlled clinical trial Parameswaran K. Nair, S. Denis, Laura Cancelliere et al. · Clinical & Experimental Allergy	2 Aug 2014	7
24	Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data Mackenzie Bergagnini-Kolev, Katie Kane, Ian E. Templeton et al. · The AAPS Journal Open access	21 Jun 2023	6
25	Inhaled calcium salts inhibit tobacco smoke-induced inflammation by modulating expression of chemokines and cytokines Paulette W. Andreotta, Steve Arold, Jennifer A. Kenyon et al. · Pulmonary Pharmacology & Therapeutics	22 Oct 2018	4
26	Design and implementation of a multi-part, flexible protocol to assess the tolerability and pharmacodynamic effects of PUR118 in healthy subjects and COPD patients Lorna Patrick, Alyson L. Connor, Stuart J. Mair et al. · European Respiratory Journal	Sep 2012	3
27	Safety, tolerability, and pharmacokinetics of a single orally inhaled dose of PUR3100 , a dry powder formulation of dihydroergotamine versus intravenous dihydroergotamine: A Phase 1 randomized, double‐blind study in healthy adults Susan Bodie, Aidan K. Curran, Aaron C. Gonzalez‐Nelson et al. · Headache The Journal of Head and Face Pain Open access	8 May 2024	2
28	SAFETY AND TOLERABILITY OF PUR1800, AN ORALLY INHALED NARROW SPECTRUM KINASE INHIBITOR, IN PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). Margaret M. Wasilewski, Russell W. Clayton, Dave Singh et al. · Journal of Allergy and Clinical Immunology	Feb 2023	1
29	Nasal and orally inhaled therapies for acute treatment of migraine Margaret M. Wasilewski, Susan Bodie · Elsevier eBooks Book chapter	Nov 2024	0
30	Inhaled cationic salts modulate macrophage function to reduce inflammation during LPS induced lung injury Steve Arold, Elizabeth L. Berry, Daniela W. Rosa et al. · European Respiratory Journal	Sep 2012	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.